Extensive Early-Phase Development Experience

● The flexibility of a true synergistic partner
● The most effective recruitment and retention programs
● The best quality and highest safety standards
● A streamlined process that simplifies the drug developmental journey



Specialty Oncology Clinical Trial Experience

WCCT’s merger with Medelis, a specialty oncology CRO, offers enhanced expertise and an expanded array of oncology clinical research services:
  • Accelerated study start-up
  • Unique access to critical global clinical research sites


h1n1 virus

The First U.S. Clinical Pharmacology Unit Able to Conduct Influenza Challenge Research

WCCT is the first and only commercially approved U.S. site that can drive and accelerate influenza challenge research through rapid enrollment of both healthy and targeted patient populations into adaptive clinical trials.



Data-Driven Patient
Recruitment Solutions

WCCT offers world-class patient recruitment services through
the use of advanced, data-driven technologies and databases to
accelerate the study start-up process.



Full-Service Global
Clinical Development Expertise

Phase II - IV: To address your company’s clinical trial
needs, WCCT and Medelis have combined site
ownership with clinical, medical and business expertise
to develop strategic full-service CRO solutions.


Clinical Expertise to Fuel Your Study

As a specialized full-service CRO, we offer global capabilities, clinical study services, research sites, medical trial support and data management, as well as innovative and adaptive trial models. We utilize a collaborative approach focused on developing your trial efficiently in key therapeutic areas:


WCCT has conducted over 120 Asian ethnobridging trials, including Japanese, Chinese, Korean, Taiwanese and other Southeast Asian countries in the last five years by having access to the largest pool of U.S. volunteers.


Our Medelis CRO team applies the breadth and depth of its portfolio of expertise to reach most targets in oncology – with faster, more accurate results and deeper strategic long-term development planning. Our strength is in our unique study start-up and ability to match sites to your specific protocol.


For 18 years, WCCT has applied its uniquely innovative, agile and collaborative approach to over 250 respiratory studies. We have been a part of the early- phase research process for nearly every approved respiratory product on the market.

Infectious Disease and Vaccines

The WCCT research unit is the only approved influenza challenge site in the U.S. We work to streamline clinical development of new vaccines, delivery systems, treatments and antimicrobial agents to post-approval quickly and effectively.


Due to our extensive early clinical development experience and emphasis on overnight confinement, WCCT and its OC Clinical Trials and Consulting unit deliver a comprehensive new level of data collection to ophthalmology studies. Additionally, WCCT offers the only Phase I facility in the U.S. that conducts and collects safety and tolerability data including PK while adding ocular endpoints including IOP, visual acuity and more.

Immunology and Allergy

WCCT integrates immunology and allergy expertise, advanced scientific research and more than 18 years of conducting complex global immunological clinical studies and research. We have leveraged our extensive allergy and immunology experience to play a significant role in the global development of immunologic studies.

Submit RFI/RFP

Tell us about your study to receive a customized proposal. Simply fill out the form below and submit your RFI/RFP. Please send attachments to: mgr@WCCT.com.

Strategically Delivered Clinical Services

Our team of translational clinical experts delivers exceptional results through innovative patient recruitment solutions and clinical trial models. To meet your individual trial requirements, each element is strategically crafted and supported by performance-driven analytics.

Early Phase

WCCT provides the most comprehensive early-phase services for your study through our wholly owned CPUs – ensuring the highest safety and quality standards utilizing our premier risk-mitigation models.

Clinical Research –
Medelis and WCCT Global

As a single-source provider for translational medicine, clinical trial planning, trial management and drug development planning, WCCT and Medelis deliver the best total solution – with all the support required – to optimize your clinical research ROI.

Research Sites

WCCT owns and operates five unique specialty clinical sites for Phase I-IV studies with both inpatient or outpatient capabilities.

Clinical Support

WCCT’s cutting-edge innovations make the trial process faster, more precise, easily trackable and more productive. Our programs are specifically designed to improve the control and monitoring of data while tracking and reporting patient outcomes, as well as managing regulatory information in real time.


Stay up-to-date on clinical research news and developments.


Careers that put you at the forefront of medical breakthroughs.


The blog delivers industry-related developments and announcements regarding expanded clinical services.